Navigation Links
The quest for a better bionic hand
Date:2/17/2013

For an amputee, replacing a missing limb with a functional prosthetic can alleviate physical or emotional distress and mean a return of vocational ability or cosmetics. Studies show, however, that up to 50 percent of hand amputees still do not use their prosthesis regularly due to less than ideal functionality, appearance, and controllability. But Silvestro Micera, of the cole Polytechnique Fdrale de Lausanne (EPFL) in Switzerland, is paving the way for new, smart prosthetics that connect directly to the nervous system. The benefits are more versatile prosthetics with intuitive motor control and realistic sensory feedbackin essence, they could one day return dexterity and the sensation of touch to an amputee.

At the 2013 Annual Meeting of the American Association for the Advancement of Science (AAAS) in Boston, Micera reports the results of previous work conducting a four-week clinical trial that improved sensory feedback in amputees by using intraneural electrodes implanted into the median and ulnar nerves. This interface holds great promise because of its ability to create an intimate and natural connection with the nerves, and because it is less invasive than other methods. It also provides fast, intuitive, bidirectional flow of information between the nervous system and the prosthetic, resulting in a more realistic experience and ultimately improved function.

"We could be on the cusp of providing new and more effective clinical solutions to amputees in the next years," says Micera, who is Head of the Translational Neural Engineering Laboratory at EPFL and Professor at the Scuola Superiore Sant'Anna in Italy. Micera and colleagues tested their system by implanting intraneural electrodes into the nerves of an amputee. The electrodes stimulated the sensory peripheral system, delivering different types of touch feelings. Then the researchers analyzed the motor neural signals recorded from the nerves and showed that information related to grasping could indeed be extracted. That information was then used to control a hand prosthesis placed near the subject but not physically attached to the arm of the amputee.

At AAAS in Boston, Micera also describes his recent activities to improve the efficacy of this approach and announces a new clinical trial starting soon as part of the Italian Ministry of Health's NEMESIS project, under the clinical supervision of Prof. Paolo M. Rossini. This new trial carries this research a step further by connecting the prosthetic hand directly to the patient for the first real-time, bidirectional control using peripheral neural signals. Though results are not yet available, the researchers hope to find still further improvement in the sensory feedback and overall control of the prosthetics with this new method.


'/>"/>

Contact: Hillary Sanctuary
hillary.sanctuary@epfl.ch
41-797-034-809
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert

Related biology technology :

1. Distinct Bright Answers Questions on Why Bacteria are Becoming Resistant to Antibiotics
2. How to Answer 20 Tough Medical Sales Job Interview Questions from Nationally Renowned Career Coach, Peggy McKee, CEO of Career Confidential
3. Quest Diagnostics Clinical Trials Biorepository Accredited by the College of American Pathologists
4. Physicians Answer Questions About Food Biotechnology in IFIC Foundation Videos
5. Maths experts question key ecological theory
6. Questcor Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
7. Questcor Pharmaceuticals Expands Repurchase Program
8. Quest Diagnostics Announces C9orf72 Genetic Test for ALS (Lou Gehrigs Disease)
9. Mars, Incorporated Answers Question: How Does Feeding People and Pets Nurture Science and Discovery? At TEDMED 2012
10. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
11. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its national ... Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based ... selected for membership in ARCS Alumni Hall of Fame . ASTER Labs ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is ... and 8th June 2018 in San Francisco, CA. The Summit brings together current and ... distinguished CEOs, board directors and government officials from around the world to address key ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
Breaking Biology News(10 mins):